BARBOLINI, MONICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.999
EU - Europa 2.312
AS - Asia 2.201
SA - Sud America 342
AF - Africa 52
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 10
Totale 8.929
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.898
IT - Italia 718
SG - Singapore 687
CN - Cina 530
GB - Regno Unito 363
IE - Irlanda 316
VN - Vietnam 247
BR - Brasile 236
HK - Hong Kong 233
DE - Germania 185
SE - Svezia 149
FI - Finlandia 117
FR - Francia 111
RU - Federazione Russa 87
BD - Bangladesh 76
IN - India 67
ID - Indonesia 63
CA - Canada 56
KR - Corea 52
TR - Turchia 49
AR - Argentina 37
UA - Ucraina 37
JP - Giappone 35
NL - Olanda 29
BE - Belgio 28
BG - Bulgaria 25
LT - Lituania 24
MX - Messico 24
PL - Polonia 24
CO - Colombia 21
ES - Italia 20
MY - Malesia 19
TW - Taiwan 19
IQ - Iraq 18
CZ - Repubblica Ceca 14
VE - Venezuela 14
EC - Ecuador 13
IR - Iran 13
AT - Austria 12
SA - Arabia Saudita 12
ZA - Sudafrica 12
AU - Australia 11
CL - Cile 11
AE - Emirati Arabi Uniti 9
EU - Europa 9
MA - Marocco 9
PK - Pakistan 9
AL - Albania 8
UZ - Uzbekistan 8
EG - Egitto 6
KE - Kenya 6
NP - Nepal 6
TH - Thailandia 6
CR - Costa Rica 5
IL - Israele 5
JM - Giamaica 5
MT - Malta 5
RO - Romania 5
RS - Serbia 5
DK - Danimarca 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
GR - Grecia 4
JO - Giordania 4
OM - Oman 4
PH - Filippine 4
BH - Bahrain 3
DZ - Algeria 3
HR - Croazia 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LK - Sri Lanka 3
NO - Norvegia 3
PE - Perù 3
PT - Portogallo 3
PY - Paraguay 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
AZ - Azerbaigian 2
BO - Bolivia 2
GA - Gabon 2
LV - Lettonia 2
MK - Macedonia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
QA - Qatar 2
SI - Slovenia 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BW - Botswana 1
BY - Bielorussia 1
BZ - Belize 1
CI - Costa d'Avorio 1
DJ - Gibuti 1
EE - Estonia 1
GT - Guatemala 1
HN - Honduras 1
Totale 8.916
Salva come PNG Salva come JPEG
Città #
Ashburn 517
Singapore 437
Santa Clara 402
Dublin 314
Chandler 310
San Jose 248
Hong Kong 221
Fairfield 219
Dallas 154
Southend 150
Hefei 142
Council Bluffs 121
Beijing 117
Nyköping 112
Woodbridge 112
Helsinki 104
Ann Arbor 99
Seattle 95
London 92
New York 90
Wilmington 89
Ho Chi Minh City 82
Houston 80
Modena 76
Cambridge 72
Los Angeles 69
The Dalles 64
Hanoi 62
Dearborn 59
Seoul 51
Milan 50
Lauterbourg 45
Jakarta 44
Bologna 41
Munich 40
Jacksonville 38
Moscow 37
Fremont 34
Shanghai 34
Rome 33
São Paulo 30
Chicago 29
San Diego 28
Redwood City 27
Sofia 24
Princeton 23
Brussels 22
Orem 21
Columbus 20
Frankfurt am Main 19
San Giuliano Milanese 19
Tokyo 19
Paris 18
Parma 18
Reggio Emilia 18
Bremen 17
Dong Ket 17
Warsaw 17
Toronto 16
Brooklyn 15
Buffalo 15
Eugene 15
Redondo Beach 15
Falls Church 14
Mumbai 14
Portsmouth 14
Phoenix 13
Florence 12
Denver 11
Düsseldorf 11
Guangzhou 11
Haiphong 11
Montreal 11
New Taipei 11
Izmir 10
Nuremberg 10
Boardman 9
Chennai 9
Poplar 9
Salt Lake City 9
Baghdad 8
Brno 8
Caprarola 8
Cardiff 8
Da Nang 8
Genoa 8
Glasgow 8
Kent 8
Stockholm 8
Tashkent 8
Charlotte 7
Istanbul 7
Johannesburg 7
Medellín 7
Melbourne 7
Mexico City 7
Norwalk 7
Quito 7
Santorso 7
Sassuolo 7
Totale 5.957
Salva come PNG Salva come JPEG
Nome #
GD2 expression in breast cancer. 425
Interstitial Lung Disease in Abemaciclib-treated Patients during SARS-CoV-2 Pandemic: A Case Series. 385
Differential molecular pathways expression in HER2 positive early breast cancer according to hormone receptor status. 383
SOLUBLE TRAIL-ARMED HUMAN AD-MSC AS NOVEL CELL THERAPY APPROACH FOR PANCREATIC DUCTAL ADENOCARCINOMA 380
Mutational Profile of Metastatic Breast Cancer Tissue in Patients Treated with Exemestane Plus Everolimus 359
Impact of body composition parameters on tumor response to neoadjuvant chemotherapy in operable breast cancer patients. 348
Clinical Prognosticators in Patients Treated with CDK 4/6 Inhibitors for Hormone Receptors Positive Advanced Breast Cancer 348
A concise review of lenalidomide therapy for follicular lymphoma 340
The evolving role of microsatellite instability in colorectal cancer: A review 339
Endocrine-based targeted combination versus endocrine therapy alone as first-line treatment in elderly patients with hormone receptor-positive advanced breast cancer: Meta-analysis of phase II and III randomized clinical trials. 338
Primary and secondary prevention to effectively reduce the risk of bisphosphonate-related osteonecrosis of the jaw in patients with bone metastases . 332
Modulation of Mutational Landscape in HER2-Positive Breast Cancer after Neoadjuvant Chemotherapy 316
Clinical-Pathological Characteristics of HER2+ Breast Cancers patients among BRCA1/2+ carriers tested in Modena Cancer Center. 288
Breast Location for De Novo Extramedullary Myeloid Sarcoma 287
Predictive Role Of Body Composition Parameters In Operable Breast Cancer Patients Treated With Neoadjuvant Chemotherapy. 282
Predictors of HER2 gene amplification in immunohistochemistry score 2+ Early Breast Cancer according to 2018 ASCO/CAP guidelines: a single institution analysis. 278
Thromboembolism (TE) and adjuvant endocrine therapy (AET) in hormone receptor positive (HR+) early breast cancer (EBC): Did the evolution of treatment change the incidence of the adverse event? A metanalysis 278
Real-World Data and Clinical Implications of Next-Generation Sequencing (NGS)-Based Analysis in Metastatic Breast Cancer Patients 270
Impact of anaemia on tumor response to neoadjuvant chemotherapy in breast cancer patients . 261
Primary treatment strategy in elderly patients with hormone receptor positive early breast cancer: is breast cancer surgery. 255
PROGNOSIS AND RESPONSE TO NEOADJUVANT CHEMOTHERAPY ACCORDING TO HER2 EXPRESSION IN EARLY BREAST CANCER: a retrospective single institution analysis 254
Combined endocrine approaches vs endocrine therapy alone as first line treatment in elderly patients with hormone receptor-positive, HER2 negative, advanced breast cancer: To prescribe for the patient or the physician? A meta-analysis of phase II and III randomized clinical trials 249
TDM-1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: A meta-analysis 231
Adjuvant exemestane or tamoxifen plus ovarian suppression in premenopausal women: single institution analysis 224
Role of Intrinsic Subtype Analysis with PAM50 in Hormone Receptors Positive HER2 Negative Metastatic Breast Cancer: A Systematic Review. 212
T-DM1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis 210
Next Generation Sequencing (NGS): a possible game changer in metastatic breast cancer 207
LETTER TO THE EDITOR: Henoch-schönlein Purpura (HSP) in a Patient on Abemaciclib 202
Adjuvant Endocrine Therapy in Premenopausal Women With Hormone Receptor-Positive Early-Stage Breast Cancer: Risk Stratification in a Real-World Setting 182
Thromboembolism and Adjuvant Endocrine Therapy (AET) in Hormone Receptor-Positive Early Breast Cancer (EBC): Did Treatment Evolution Change Incidence of the Adverse Event? A Meta-Analysis 179
TDM-1 efficacy in trastuzumabpertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis 157
Safety and efficacy analysis of neoadjuvant pertuzumab, trastuzumab and standard chemotherapy for HER2–positive early breast cancer: real–world data from NeoPowER study 155
Update on Pulmonary Toxicity Induced by New Breast Cancer Treatments. 33
Totale 8.987
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.837
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.837
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202148 0 0 0 0 0 0 0 0 0 0 0 48
2021/2022625 43 79 34 22 27 55 31 38 58 43 113 82
2022/20231.154 84 128 89 80 82 91 26 84 367 32 46 45
2023/2024648 31 35 62 65 61 57 78 62 35 36 64 62
2024/20251.718 58 35 61 119 325 239 131 108 188 106 140 208
2025/20263.486 238 98 317 331 447 219 528 198 359 363 280 108
Totale 8.987